# A Viveve Experience Normalizes Untreated Selective Serotonin Reuptake Inhibitor (SSRI) Sexuality Syndrome

> **NCT03679702** · NA · UNKNOWN · sponsor: **Michael Krychman, MD** · enrollment: 10 (estimated)

## Conditions studied

- Sexual Dysfunction

## Interventions

- **DEVICE:** Viveve System

## Key facts

- **NCT ID:** NCT03679702
- **Lead sponsor:** Michael Krychman, MD
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-12-15
- **Primary completion:** 2019-12-01
- **Final completion:** 2019-12-01
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2018-11-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03679702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03679702, "A Viveve Experience Normalizes Untreated Selective Serotonin Reuptake Inhibitor (SSRI) Sexuality Syndrome". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03679702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*